Objective: To compare the e ectiveness of bubble continuous positive airway pressure (bCPAP) and oxygen inhalavtiioan nasal cannula in neonates presenting with respiratory distress, using Silverman Anderson Retraction Score (SARS). Study Design: Randomised clinical trial. Place and Duration of Study: Department of Paediatrics, Unit-1, KEMU/Mayo Hospital, Lahore, Pakistan, from April 2017 to June 2018. Methodology: A total of 120 neonates ful lling inclusion and exclusion criteria were enrolled and were randomly allocated in two groups: Group A and Group B. In group A, neonates were given bCPAP for respiratory support, while neonates in group B were given nasal oxygen as control group. Neonates in both groups were followed for 48 hours. The e ectiveness was determined by the reduction in SARS, up to or less than score 3, at the end of a 48-hour period. Data were collected and analysed by SPSS version 20.0. P-value d0.05 was taken as signi cant. Results: In Group A, e ectiveness was found to be 93.3%, and in Group B e ectiveness was 71.7% (p = 0.003). Median reduction in SARS from 00 to 48 hours, in group A (bCPAP) was 4 (4 5) while in group B (control), it was 3 (2 3); statistically signi cant (p <0.001). Conclusion: Bubble CPAP was more e ective than nasal oxygen alone, in treatment of respiratory distress among neonates. This study suggested that bCPAP should be used more frequently in NICUs of Pakistan to reduce burden of neonatal morbidity due to respiratory distress.